FIELD: medicine.
SUBSTANCE: claimed method includes paracentesis of pleural cavity and exudate removing by at least tree hours before surgical aggression singly and then additionally over at least one day after surgical aggression. Interval between paracentesis must be not less than one day. After exudate removing during each paracentesis 2000 Units of contrical and 30 mg of mexidole are administered intrapleurally.
EFFECT: method for treatment of increased effectiveness due to improving of ventilation-perfusion ratio and reducing of amylasemia in pleural cavity exudate.
1 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT OF PANCREATOGENIC EXUDATIVE PLEURISY | 2017 |
|
RU2657621C1 |
METHOD TO TREAT PNEUMONIA | 2001 |
|
RU2177787C1 |
METHOD OF TREATING PATIENTS WITH PLEURAL EFFUSION OF VARIOUS AETIOLOGY | 2013 |
|
RU2570527C2 |
METHOD FOR DETECTING INDICATIONS FOR LOW-INVASIVE INTERFERENCES IN CASE OF EXUDATIVE PLEURITIS IN CHILDREN | 2000 |
|
RU2207051C2 |
METHOD OF TREATING PATIENTS WITH TUBERCULOUS EXUDATIVE PLEURITIS | 2012 |
|
RU2491089C1 |
INTEGRATED TREATMENT OF MALIGNANT TUMOUR PLEURA INVOLVEMENT ACCOMPANIED WITH EXUDATIVE PLEURISY | 2008 |
|
RU2358775C1 |
METHOD OF PLEURODESIS WITH SILVER-ALLOYED TITANIUM NICKELIDE POWDER | 2023 |
|
RU2810367C1 |
METHOD OF FLUID RESORPTION IN CASE OF TUBERCULOSIS PLEURITES | 2010 |
|
RU2440830C1 |
METHOD FOR TREATING BILATERAL TUMOR PLEURITIS | 2002 |
|
RU2225231C1 |
METHOD FOR TREATMENT OF PATIENTS WITH ENCYSTED TUBERCULOSIS PLEURITIS | 2003 |
|
RU2239437C1 |
Authors
Dates
2006-11-10—Published
2004-12-28—Filed